Karyopharm Therapeutics股价上涨18%，私下筹集3000万美元

2026-03-24 19:57

Karyopharm Therapeutics (KPTI) announced a $30M private placement specifically with RA Capital and an additional ~$44M of gross proceeds if the accompanying warrants are exercised in full.
In the private placement, the company agreed to sell ~1.03M shares at a price of $6.785 per share, ~3.39M pre-funded warrants at a price of $6.7849 per pre-funded warrant, and accompanying warrants to purchase ~4.42M shares with an exercise price of $10.00 per share.
The proceeds will be used for general corporate purposes, including to support the company's ongoing and planned clinical trial activities.
The private placement is expected to close on or about March 26, 2026.
The stock price jumped ~18% to $7.81 on Tuesday during pre-market hours of trading.

More on Karyopharm Therapeutics